MOBILion Systems is enabling advancements in disease diagnosis and treatment by commercializing instruments to separate, identify and analyze the most challenging molecules that other instruments fail to detect. MOBILion’s separations technology provides higher resolution, faster analysis and simpler workflows to reveal molecules that are most important in characterizing biologic therapeutics, discovering biomarkers, and improving the accuracy of diagnostic tests. Processing population-scale samples in days versus years and detecting molecules other instruments miss make treatments safer and more effective, accelerate disease prediction and diagnosis, and enhance the development of new therapies. The company is headquartered in Chadds Ford, Pennsylvania within the Philadelphia biopharmaceutical and medical innovation corridor.

Join Jim Arndt, Ph.D for a Technical Seminar on Tuesday, February 2nd from 10:50 - 11:20 EST

Check out our Twitter for live updates on technical seminars, conference events and recaps

MOBIE (@MOBIE_Mobility) / Twitter